HIGHLIGHTS
- who: Report and colleagues from the Emergency Medicine, HCA Houston Kingwood/University of Houston College of Medicine, Kingwood, USA , have published the article: Review began 05/23/2022 Review ended 05/28/2022 Published 05/31/2022 u00a9 Copyright, in the Journal: (JOURNAL) of May/31,/2022
- what: The authors report a patient who had a Pipeline Flex Embolization Device with Shield Technology who only underwent 31 days of DAPT followed by ASA 81 mg and had no evidence of stenosis.
- future: Future research should determine the optimal duration of DAPT following 2022 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.